- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Anthem Biosciences Limited — Updates, 21-07-2026: Press Release
21-07-2026 | 04:49 pm
21-07-2026 | 04:49 pm
Anthem reports Q1FY27 consolidated revenue of ₹418.2 Cr, EBITDA ₹175.5 Cr (39.6% margins), and PAT ₹119.9 Cr (27.1% margins). Management notes Q1 reflects delivery timing shifts; strong demand and higher deliveries are expected in H2, sustaining revenue growth and industry-leading margins.
No comments yet. Be the first to comment!